These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 8853743

  • 1. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A, Murri R, Ammassari A.
    AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S, Finkelstein DM, Feinberg J, Frame P, Simpson G, Wu A, Cheung T, Soeiro R, Hojczyk P, Black JR.
    Ann Intern Med; 1996 May 01; 124(9):792-802. PubMed ID: 8610948
    [Abstract] [Full Text] [Related]

  • 3. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD, Rimland D.
    AIDS; 1999 May 28; 13(8):991-2. PubMed ID: 10371182
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC, Griffith L, Guyatt GH, Opravil M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun 01; 15(2):104-14. PubMed ID: 9241108
    [Abstract] [Full Text] [Related]

  • 6. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM, Murphy RL, Yurik TM, Luskin-Hawk R, Cheung TW, Balfour HH, Eng R, Hooton TM, Kerkering TM, Schutz M, van der Horst C, Hafner R.
    N Engl J Med; 1998 Dec 24; 339(26):1889-95. PubMed ID: 9862944
    [Abstract] [Full Text] [Related]

  • 7. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE, Kossey JL.
    Ann Pharmacother; 1998 Dec 24; 32(12):1302-5. PubMed ID: 9876811
    [Abstract] [Full Text] [Related]

  • 8. Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole.
    Klinker H, Langmann P, Zilly M, Richter E.
    J Clin Pharm Ther; 1998 Apr 24; 23(2):149-54. PubMed ID: 9786102
    [Abstract] [Full Text] [Related]

  • 9. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
    Huang L, Morris AM, Beard CB.
    J Eukaryot Microbiol; 2001 Apr 24; Suppl():180S-181S. PubMed ID: 11906054
    [No Abstract] [Full Text] [Related]

  • 10. Severe and long lasting cholestasis after high-dose co-trimoxazole treatment for Pneumocystis pneumonia in HIV-infected patients--a report of two cases.
    Hanses F, Zierhut S, Schölmerich J, Salzberger B, Wrede CE.
    Int J Infect Dis; 2009 Nov 24; 13(6):e467-9. PubMed ID: 19299179
    [Abstract] [Full Text] [Related]

  • 11. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
    Smith CL, Brown I, Torraca BM.
    Clin Infect Dis; 1997 Dec 24; 25(6):1477-8. PubMed ID: 9431404
    [No Abstract] [Full Text] [Related]

  • 12. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
    Fisk M, Sage EK, Edwards SG, Cartledge JD, Miller RF.
    Int J STD AIDS; 2009 Sep 24; 20(9):652-3. PubMed ID: 19710343
    [Abstract] [Full Text] [Related]

  • 13. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, Benowitz N, Wofsy CB.
    N Engl J Med; 1990 Sep 20; 323(12):776-82. PubMed ID: 2392131
    [Abstract] [Full Text] [Related]

  • 14. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
    Barber BA, Pegram PS, High KP.
    Clin Infect Dis; 1996 Oct 20; 23(4):718-22. PubMed ID: 8909833
    [Abstract] [Full Text] [Related]

  • 15. [Hypersensitivity cross-reaction with dapsone and cotrimoxazole in a patient infected by the human immunodeficiency virus].
    Jiménez-Lozano I, Alcalde M, Campany Herrero D, Monterde J.
    Farm Hosp; 2013 Oct 20; 37(4):335-6. PubMed ID: 24010695
    [No Abstract] [Full Text] [Related]

  • 16. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
    Beumont MG, Graziani A, Ubel PA, MacGregor RR.
    Am J Med; 1996 Jun 20; 100(6):611-6. PubMed ID: 8678080
    [Abstract] [Full Text] [Related]

  • 17. Use of dapsone in the treatment of Pneumocystis carinii pneumonia in a foal.
    Clark-Price SC, Cox JH, Bartoe JT, Davis EG.
    J Am Vet Med Assoc; 2004 Feb 01; 224(3):407-10, 371. PubMed ID: 14765801
    [Abstract] [Full Text] [Related]

  • 18. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A, Murri R, Ammassari A, De Luca A, Linzalone A, Cingolani A, Damiano F, Maiuro G, Vecchiet J, Scoppettuolo G.
    AIDS; 1995 Dec 01; 9(12):1343-50. PubMed ID: 8605054
    [Abstract] [Full Text] [Related]

  • 19. Iron overload as a mechanism for the lowered survival in AIDS patients receiving dapsone-iron protoxalate for secondary prophylaxis of Pneumocystis carinii pneumonia.
    Weinberg GA.
    J Infect Dis; 1996 Jul 01; 174(1):241-2. PubMed ID: 8656006
    [No Abstract] [Full Text] [Related]

  • 20. Does dapsone increase mortality when given for prophylaxis of Pneumocystis carinii pneumonia?
    Opravil M, Hirschel B, Lüthy R.
    AIDS; 1996 Aug 01; 10(9):1045-6. PubMed ID: 8853742
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.